<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27162136</identifier>
<setSpec>1130-1473</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Guridi, Jorge</dc:author>
<dc:author>Becerra, Victoria</dc:author>
<dc:author>Parras, Olga</dc:author>
<dc:author>Marigil, Miguel</dc:author>
<dc:description xml:lang="en">Subthalamic nucleus hyperactivity in Parkinson's disease may be a very early phenomenon. Its start is not well known, and it may occur during the pre-symptomatic disease stage. Glutamatergic hyperactivity may be neurotoxic over the substantia nigra compacta dopaminergic neurons. If this occurred, the excitatory neurotransmitter, glutamate, should affect the neurons that maintain a high turnover as a compensatory mechanism. Would a subthalamic nucleus lesion decrease this hyperactivity and thus be considered as a neuroprotective mechanism for dopaminergic neurons? The authors hypothesise about the possibility to perform surgery on a subthalamic nucleus lesion at a very early stage in order to avoid the neurotoxic glutamatergic effect over the dopaminergic neurons, and therefore be considered as a neuroprotective surgery able to alter the progress of the disease during early motor symptoms. In this regard, magnetic resonance-guided focused ultrasound techniques open a new window in the stereotactic armamentarium.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Núcleo subtalámico</dc:subject>
<dc:subject>Neuroprotection</dc:subject>
<dc:subject>Enfermedad de Parkinson</dc:subject>
<dc:subject>Neurotoxicity</dc:subject>
<dc:subject>Magnetic resonance-guided focused ultrasound</dc:subject>
<dc:subject>Parkinson's disease</dc:subject>
<dc:subject>Ultrasonidos focalizados por resonancia</dc:subject>
<dc:subject>Subthalamic nucleus</dc:subject>
<dc:subject>Neuroprotección</dc:subject>
<dc:subject>Neurotoxicidad</dc:subject>
<dc:date>2016 Nov - Dec </dc:date>
<dc:title xml:lang="es">Subtalamotomía como neuroprotección en la enfermedad de Parkinson. El papel de los ultrasonidos guiados por resonancia como cirugía temprana.</dc:title>
<dc:title xml:lang="en">[Neuroprotective subthalamotomy in Parkinson's disease. The role of magnetic resonance-guided focused ultrasound in early surgery].</dc:title>
<dc:publisher>Neurocirugia (Asturias, Spain)</dc:publisher>
</metadata>
</record>
</pubmed-document>
